Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...
With snow having made an appearance back in January, I've started to consider some of the best thermal leggings to add to my winter wardrobe in order to keep me warm. Now might not be the best time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results